Abstract

Active autophagy coupled with rapid mitochondrial fusion and fission constitutes an important mitochondrial quality control mechanism and is critical to cellular health. In our previous studies, we found that exposure of cells to nicotinamide causes a decrease in mitochondrial content and an increase in mitochondrial membrane potential (MMP) by activating autophagy and inducing mitochondrial fragmentation. Here, we present evidence to show that the effect of nicotinamide is mediated through an increase of the [NAD(+)]/[NADH] ratio and the activation of SIRT1, an NAD(+)-dependent deacetylase that plays a role in autophagy flux. The [NAD(+)]/[NADH] ratio was inversely correlated with the mitochondrial content, and an increase in the ratio by the mobilization of the malate-aspartate shuttle resulted in autophagy activation and mitochondrial transformation from lengthy filaments to short dots. Furthermore, treatment of cells with SIRT1 activators, fisetin or SRT1720, induced similar changes in the mitochondrial content. Importantly, the activators induced mitochondrial fragmentation only when SIRT1 expression was intact. Meanwhile, MMP did not increase when the cells were treated with the activators, suggesting that the change in MMP is not induced by the mitochondrial turnover per se and that elevation of the [NAD(+)]/[NADH] ratio may activate additional mechanisms that cause MMP augmentation. Together, our results indicate that a metabolic state resulting in an elevated [NAD(+)]/[NADH] ratio can modulate mitochondrial quantity and quality via pathways that may include SIRT1-mediated mitochondrial autophagy.

Highlights

  • Nicotinamide treatment decreases mitochondrial content and helps cells maintain high mitochondrial quality

  • NAM is readily converted to NADϩ through the salvage pathway; the first step of this pathway is the conversion of NAM to nicotinamide mononucleotide (NMN), which is mediated by NAM phosphoribosyltransferase (NAMPT) [26]

  • Treatment of cells with 1 mM NMN, which caused an increase in the level of basal [NADϩ] by nearly 40 –50% (Fig. 1C (NMN)), resulted in a decrease in the mitochondrial content to the level achieved by NAM treatment, NAM co-treatment did not cause any further decrease (Fig. 1D (NMN))

Read more

Summary

Background

Nicotinamide treatment decreases mitochondrial content and helps cells maintain high mitochondrial quality. Results: Metabolically enhanced NADϩ/NADH ratio and chemically induced SIRT1 activation decreased mitochondrial content, increased autophagy, and induced mitochondrial fragmentation. Defective ETCs produce large amounts of reactive oxygen species (ROS) and thereby play a major role in the induction of cellular senescence and possibly tissue aging and are strongly associated with various aging-associated degenerative diseases and cancers as well [2, 3] For this reason, maintenance of mitochondria quality is of utmost importance to body health and longevity [4]. We demonstrated that the treatment of human fibroblasts with 5 mM NAM activates autophagy and causes a decrease in mitochondrial content and ROS levels, while increasing mitochondrial membrane potential (MMP). We examined the involvement of high cellular [NADϩ]/[NADH] ratios and SIRT1 activation in the NAMinduced decrease of the mitochondrial content and their transformations. Our results show that cellular NADϩ metabolism modulates mitochondrial content through pathways that might involve SIRT1 activation

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call